VAN LANSCHOT KEMPEN Life Sciences Conference


April 26, 2023

Amsterdam

Downloads

Past events

J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco


January 9 to 11, 2023

San Francisco

Downloads

Conference Call & Webcast – CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs


January 6, 2023

CureVac N.V. (Nasdaq: CVAC) today announced positive preliminary data from ongoing Phase 1 clinical programs in COVID-19 and seasonal flu, assessing both modified and unmodified mRNA technology.
The company hosted a conference call and webcast. Please find below the download link for the press release and the presentation slides as well as the link to the on demand version of the webcast.

The JMP Securities Hematology and Oncology Summit


December 6, 2022

Virtual

Downloads

5th Annual Evercore ISI HealthCONx Conference


November 29, 2022

Virtual

Downloads

Jefferies London Healthcare Conference


November 17, 2022

London

Downloads

Third Quarter and First Nine Months 2022 Financial Results and Business Updates – Conference Call & Webcast


November 16, 2022

CureVac N.V. (Nasdaq: CVAC) has reported financial results and provided business updates for the third quarter and first nine months of 2022 on Wednesday, November 16, 2022. The company hosted a conference call and webcast on the same day.

Please find the corresponding press release and presentation slides below. A link to the replay of the webcast will be made available shortly.

10th International mRNA Health Conference


November 8-10, 2022

Boston

Downloads

Berenberg and Goldman Sachs Eleventh German Corporate Conference


September 20, 2022

Munich

Downloads

Morgan Stanley 20th Annual Global Healthcare Conference


September 12, 2022

New York

Downloads

VAN LANSCHOT KEMPEN Life Sciences Conference


April 26, 2023

Amsterdam

Downloads

J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco


January 9 to 11, 2023

San Francisco

Downloads

Conference Call & Webcast – CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs


January 6, 2023

CureVac N.V. (Nasdaq: CVAC) today announced positive preliminary data from ongoing Phase 1 clinical programs in COVID-19 and seasonal flu, assessing both modified and unmodified mRNA technology.
The company hosted a conference call and webcast. Please find below the download link for the press release and the presentation slides as well as the link to the on demand version of the webcast.

The JMP Securities Hematology and Oncology Summit


December 6, 2022

Virtual

Downloads

5th Annual Evercore ISI HealthCONx Conference


November 29, 2022

Virtual

Downloads

Jefferies London Healthcare Conference


November 17, 2022

London

Downloads

Third Quarter and First Nine Months 2022 Financial Results and Business Updates – Conference Call & Webcast


November 16, 2022

CureVac N.V. (Nasdaq: CVAC) has reported financial results and provided business updates for the third quarter and first nine months of 2022 on Wednesday, November 16, 2022. The company hosted a conference call and webcast on the same day.

Please find the corresponding press release and presentation slides below. A link to the replay of the webcast will be made available shortly.

Berenberg and Goldman Sachs Eleventh German Corporate Conference


September 20, 2022

Munich

Downloads

Morgan Stanley 20th Annual Global Healthcare Conference


September 12, 2022

New York

Downloads

The JMP Securities Life Sciences Conference


June 15, 2022

New York

Downloads

Jefferies Healthcare Conference


June 9, 2022

New York

Downloads

UBS – 2022 Global Healthcare Conference


June 1, 2022

Virtual

Downloads

BofA Securities 2022 Healthcare Conference


May 10, 2022

Las Vegas

Downloads

Fourth Quarter and Full-Year 2021 Financial Results and Business Updates – Conference Call & Webcast


April 28, 2022

CureVac N.V. (Nasdaq: CVAC) has reported financial results, and provided business updates for the fourth quarter and full-year 2021 on Thursday, April 28, 2022. On the same day, the company hosted a conference call and webcast.

Please find the corresponding press release and presentation slides below. An archived webcast will also be made available through the same link on the CureVac website shortly.

15th Kempen Life Sciences Conference


April 20, 2022

Amsterdam, The Netherlands

Downloads

Links

Berenberg European Conference


December 8, 2021

Virtual

Conference Call & Webcast: Third Quarter and First Nine Months 2021 Financial Results and Business Updates


November 19, 2021

CureVac N.V. (Nasdaq: CVAC) reported financial results and business updates for the third quarter and first nine months of 2021 on Friday, November 19, 2021. The company hosted a conference call and webcast on the same day at 2:00 p.m. CET / 08:00 a.m. EST.

Please find the corresponding press release, presentation slides, transcript and the archived webcast below.

Conference Call & Webcast: Focus Shift to Second-Generation mRNA Technology


October 12, 2021

CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announced on Tuesday, October 12, 2021 the strategic decision to focus its COVID-19 vaccine development towards the development of second-generation mRNA vaccine candidates in collaboration with GSK and to withdraw its first-generation COVID-19 vaccine candidate, CVnCoV, from the current approval process with the European Medicines Agency (EMA).

The company hosted a conference call and webcast on the same day at 03:00 p.m. CEST / 09:00 a.m. EST.

Please find the corresponding press release, presentation slides, transcript as well as an archived webcast below.

CureVac to Report Second Quarter and First-Half of 2021 Financial Results and Business Updates


August 16, 2021

CureVac N.V. to report financial results and business updates for the second quarter and first-half of 2021 on Monday, August 16, 2021.

Fourth Quarter and Full-Year 2020 Financial Results and Business Updates – Conference Call & Webcast


April 15, 2021

CureVac N.V. (Nasdaq: CVAC) reported financial results and business updates for the fourth quarter and full-year of 2020 on Thursday, April 15, 2021, at 4:00 p.m. CET / 10:00 a.m. EST.

Please find the corresponding press release, presentation slides, transcript as well as the archived webcast below.

Third Quarter and First 9 Months 2020 Financial Results and Business Updates – Conference Call & Webcast


November 30, 2020

CureVac N.V. (Nasdaq: CVAC) announced financial results and business updates for the third quarter and first nine months of 2020 on Monday, November 30, 2020. The company hosted a conference call and webcast on the same day at 4:00 p.m. CET / 10:00 a.m. EST.

Please find the corresponding press release, presentation slides, transcript and archived webcast below.

The JMP Securities Life Sciences Conference


June 15, 2022

New York

Downloads

Jefferies Healthcare Conference


June 9, 2022

New York

Downloads

UBS – 2022 Global Healthcare Conference


June 1, 2022

Virtual

Downloads

BofA Securities 2022 Healthcare Conference


May 10, 2022

Las Vegas

Downloads

Fourth Quarter and Full-Year 2021 Financial Results and Business Updates – Conference Call & Webcast


April 28, 2022

CureVac N.V. (Nasdaq: CVAC) has reported financial results, and provided business updates for the fourth quarter and full-year 2021 on Thursday, April 28, 2022. On the same day, the company hosted a conference call and webcast.

Please find the corresponding press release and presentation slides below. An archived webcast will also be made available through the same link on the CureVac website shortly.

15th Kempen Life Sciences Conference


April 20, 2022

Amsterdam, The Netherlands

Downloads

Links

Berenberg European Conference


December 8, 2021

Virtual